Article Review: Beyond similarities overall survival and prognostic insights from Lu Lu DOTATOC therapy in neuroendocrine tumors

Objectives This study evaluates the overall survival (OS) and prognostic factors for neuroendocrine tumor (NET) patients treated with [177Lu]Lu-DOTATOC peptide receptor radionuclide therapy (PRRT). Core contributions include: Reporting a median OS o...